FDA Calls for Enhanced Supply Chain Oversight in Infant Formula Industry
The FDA urges infant formula manufacturers to strengthen supply chain oversight to mitigate contamination risks, highlighting recent public health events. This initiative impacts procurement strategies and regulatory compliance, emphasizing the importance of supplier verification and safety monitoring.